CAROLE BEN-MAIMON Insider Trading $IPXL Impax Laboratories, LLC
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for CAROLE BEN-MAIMON.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of CAROLE BEN-MAIMON. CAROLE BEN-MAIMON is Director in Teligent, Inc. ($TLGT) and President, Global Pharm. in IMPAX LABORATORIES INC ($IPXL) and President, Global Pharm. Div. in IMPAX LABORATORIES INC ($IPXL) and President and CEO in Larimar Therapeutics, Inc. ($ZFGN).
CAROLE BEN-MAIMON in Impax Laboratories, LLC
Trading Symbol: IPXLIndustry: PHARMACEUTICAL PREPARATIONS [2834]
Position of CAROLE BEN-MAIMON: President, Global Pharm. Div.
Holdings: 85,914 shares
Current Value: $1,138,361
Latest Transaction: May 16 2014
$IPXL Market Capitalization: $952.26M
$IPXL Previous Close: $13.25
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of CAROLE BEN-MAIMON in Impax Laboratories, LLC
1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
---|---|---|---|---|---|---|---|
No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, IPXL, LRMR, TLGT
Page: 1
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 16 2014 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Option Exercise | A | 25.24 | 55,000 | 1,388,200 | 55,000 | |
May 16 2014 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Grant | A | 0.00 | 23,000 | 0 | 85,914 | 62.9 K to 85.9 K (+36.56 %) |
Oct 28 2013 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Option Exercise | M | 18.93 | 6,734 | 127,475 | 47,138 | |
Oct 28 2013 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Buy | M | 18.93 | 6,734 | 127,475 | 62,914 | 56.2 K to 62.9 K (+11.99 %) |
Oct 15 2013 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Option Exercise | M | 18.93 | 5,282 | 99,988 | 21,128 | |
Oct 15 2013 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Buy | M | 18.93 | 5,282 | 99,988 | 56,180 | 50.9 K to 56.2 K (+10.38 %) |
May 28 2013 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Payment of Exercise | F | 18.60 | 399 | 7,421 | 50,898 | 51.3 K to 50.9 K (-0.78 %) |
May 16 2013 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Option Exercise | A | 17.99 | 52,000 | 935,480 | 52,000 | |
May 16 2013 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Grant | A | 0.00 | 24,800 | 0 | 51,297 | 26.5 K to 51.3 K (+93.60 %) |
Oct 29 2012 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Payment of Exercise | F | 24.34 | 1,836 | 44,688 | 26,497 | 28.3 K to 26.5 K (-6.48 %) |
May 25 2012 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Option Exercise | A | 20.90 | 10,833 | 226,410 | 10,833 | |
May 25 2012 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Grant | A | 0.00 | 4,333 | 0 | 28,333 | 24 K to 28.3 K (+18.05 %) |
Nov 01 2011 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Option Exercise | A | 18.93 | 75,000 | 1,419,750 | 75,000 | |
Nov 01 2011 | IPXL | IMPAX LABORATORIES ... | BEN-MAIMON CAROLE | President, Global P ... | Grant | A | 0.00 | 24,000 | 0 | 24,000 | 0 to 24 K |
Page: 1